Lab on a Chip

Lab on a Chip

In this episode, Jeremy Schmerer and Ryan LaRanger discuss the idea of a “Lab on a Chip,” which allows for better screening and discovery work. One example involves the ability to simulate potential drug development failures early in the process, before they become extremely expensive to the drug maker.  Other subjects addressed include:

  • Cardio Toxicity
  • Biomarkers
  • Chemotherapeutics
  • Animal Models
  • Testing Cost and Scalability

If you have any questions, comments, or suggestions for topics to discuss, please contact Jeremy Schmerer, Healthcare & Life Sciences Lead, directly at If you would like to know if we can help your business with its innovation challenges, you can contact Jeremy or leave your info here.

Never miss an insight

Get insights delivered right to your inbox

More of Our Insights & Work
Popup Builder Mailchimp extension requires authentication.